{
    "hands_on_practices": [
        {
            "introduction": "The effectiveness of penicillins is closely tied to the duration their concentration remains above the pathogen's minimum inhibitory concentration (MIC). This foundational exercise guides you through a steady-state pharmacokinetic calculation to determine the \"fraction of time above MIC\" ($fT > \\text{MIC}$), a key predictor of therapeutic success. Mastering this calculation is the first step toward optimizing antibiotic dosing. ",
            "id": "4970540",
            "problem": "A patient with a Gram-negative infection is treated with an antipseudomonal penicillin plus a β-lactamase inhibitor by intravenous (IV) bolus dosing. Assume a one-compartment, linear pharmacokinetic model with first-order elimination and instantaneous mixing. The following parameters are known: volume of distribution per kilogram $V_d=0.3\\,\\mathrm{L/kg}$, clearance per kilogram $Cl=0.06\\,\\mathrm{L/kg/h}$, unbound (free) fraction in plasma $f_u=0.7$, adult body weight $70\\,\\mathrm{kg}$, dose $2\\,\\mathrm{g}$ every $6\\,\\mathrm{h}$, and minimal inhibitory concentration (MIC) $4\\,\\mathrm{mg/L}$. Define the fraction of the dosing interval during which free drug concentrations exceed the minimal inhibitory concentration (fraction of time above MIC for free drug, $fT > \\text{MIC}$) as the ratio of the time within a dosing interval that $f_u \\times C(t)$ is strictly greater than MIC to the dosing interval length. Starting only from the definitions of first-order elimination in a one-compartment model, conservation of mass, and linear protein binding, derive the necessary expressions and compute the expected $fT > \\text{MIC}$ per dosing interval at pharmacokinetic steady state. Express your final result as a unitless decimal fraction per dosing interval, not as a percentage.",
            "solution": "The user has provided a pharmacokinetic problem to be solved.\n\n### Step 1: Extract Givens\n-   **Model**: One-compartment, linear pharmacokinetic model, first-order elimination, instantaneous mixing.\n-   **Dosing**: Intravenous (IV) bolus.\n-   **Volume of distribution per kilogram**: $V_d = 0.3\\,\\mathrm{L/kg}$.\n-   **Clearance per kilogram**: $Cl = 0.06\\,\\mathrm{L/kg/h}$.\n-   **Unbound (free) fraction in plasma**: $f_u = 0.7$.\n-   **Adult body weight**: $W = 70\\,\\mathrm{kg}$.\n-   **Dose**: $D = 2\\,\\mathrm{g}$.\n-   **Dosing interval**: $\\tau = 6\\,\\mathrm{h}$.\n-   **Minimal inhibitory concentration**: $\\text{MIC} = 4\\,\\mathrm{mg/L}$.\n-   **Target parameter**: Fraction of time above MIC for free drug, $fT > \\text{MIC}$.\n-   **Definition of target parameter**: The ratio of the time within a dosing interval that $f_u \\times C(t)$ is strictly greater than MIC to the dosing interval length.\n-   **Condition**: At pharmacokinetic steady state.\n-   **Derivation Requirement**: Start from first-order elimination in a one-compartment model, conservation of mass, and linear protein binding.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, describing a standard scenario in clinical pharmacokinetics. All terms ($V_d$, $Cl$, $f_u$, MIC, $fT > \\text{MIC}$) are well-defined and standard in the field. The provided values are biophysically realistic for a penicillin-class antibiotic. The problem is well-posed, with sufficient information to calculate a unique, meaningful solution. It is objective and free of ambiguity. No violations of scientific principles, logical inconsistencies, or missing information are found.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be derived.\n\n### Derivation\nThe problem requires the derivation of the fraction of the dosing interval, $\\tau$, for which the free drug concentration, $C_u(t)$, exceeds the minimal inhibitory concentration, MIC. This is denoted as $fT > \\text{MIC}$.\n\n**1. One-Compartment Model Dynamics**\nIn a one-compartment model, the body is treated as a single, well-mixed volume, $V$. Conservation of mass for the drug amount, $A(t)$, in the compartment is described by a differential equation. After an IV bolus, there is no further input, and the rate of change of $A(t)$ is equal to the rate of elimination.\nFor first-order elimination, the rate of elimination is proportional to the concentration, $C(t)$. The proportionality constant is the clearance, $Cl_{total}$.\n$$\n\\frac{dA(t)}{dt} = -Cl_{total} \\times C(t)\n$$\nThe concentration is the amount per unit volume, $C(t) = A(t)/V$. Substituting this into the mass balance equation, and noting that $V$ is constant:\n$$\nV \\frac{dC(t)}{dt} = -Cl_{total} \\times C(t)\n$$\nRearranging gives the standard first-order decay equation:\n$$\n\\frac{dC(t)}{dt} = -\\frac{Cl_{total}}{V} C(t)\n$$\nWe define the first-order elimination rate constant, $k_e$, as:\n$$\nk_e = \\frac{Cl_{total}}{V}\n$$\nThe differential equation becomes $\\frac{dC(t)}{dt} = -k_e C(t)$. For a single IV bolus dose $D$ administered at $t=0$, the initial concentration is $C(0) = D/V$. The solution to this differential equation is:\n$$\nC(t) = C(0) \\exp(-k_e t) = \\frac{D}{V} \\exp(-k_e t)\n$$\n\n**2. Steady-State Pharmacokinetics with Multiple Dosing**\nFor a drug administered as an IV bolus of dose $D$ every dosing interval $\\tau$, the concentrations at steady state fluctuate between a maximum (peak), $C_{max}^{ss}$, and a minimum (trough), $C_{min}^{ss}$.\nLet $t'$ be the time elapsed since the last dose within a steady-state interval, so $t' \\in [0, \\tau)$.\nImmediately after a dose at $t'=0$, the concentration is $C_{max}^{ss}$. This is the sum of the trough concentration from all previous doses, $C_{min}^{ss}$, and the concentration increase from the new dose, $D/V$.\n$$\nC_{max}^{ss} = C_{min}^{ss} + \\frac{D}{V}\n$$\nDuring the interval, the concentration decays exponentially:\n$$\nC(t') = C_{max}^{ss} \\exp(-k_e t')\n$$\nAt the end of the interval, $t'=\\tau$, the concentration is the trough concentration, $C_{min}^{ss}$.\n$$\nC_{min}^{ss} = C_{max}^{ss} \\exp(-k_e \\tau)\n$$\nWe solve this system of two linear equations for $C_{max}^{ss}$ and $C_{min}^{ss}$. Substituting the second equation into the first:\n$$\nC_{max}^{ss} = C_{max}^{ss} \\exp(-k_e \\tau) + \\frac{D}{V}\n$$\n$$\nC_{max}^{ss} (1 - \\exp(-k_e \\tau)) = \\frac{D}{V}\n$$\n$$\nC_{max}^{ss} = \\frac{D/V}{1 - \\exp(-k_e \\tau)}\n$$\nAnd for the trough concentration:\n$$\nC_{min}^{ss} = C_{max}^{ss} \\exp(-k_e \\tau) = \\frac{D/V \\cdot \\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)}\n$$\n\n**3. Calculation of $fT > \\text{MIC}$**\nThe target is the fraction of time the free drug concentration, $C_u(t')$, is strictly greater than the MIC. Linear protein binding implies a constant unbound fraction, $f_u$, such that $C_u(t') = f_u \\times C(t')$. The condition is $f_u C(t') > \\text{MIC}$.\nThe concentration $C(t')$ is a monotonically decreasing function over the interval $t' \\in [0, \\tau)$. Its minimum value is $C_{min}^{ss}$. Consequently, the minimum free concentration is $C_{u,min}^{ss} = f_u C_{min}^{ss}$.\nWe must first evaluate if the free concentration ever drops below the MIC. We compare the minimum free concentration, $f_u C_{min}^{ss}$, to the MIC.\nIf $f_u C_{min}^{ss} > \\text{MIC}$, then for all $t' \\in [0, \\tau)$, $C_u(t') \\ge f_u C_{min}^{ss} > \\text{MIC}$. The free concentration is always above the MIC. The time duration for which this condition holds is the entire interval, $\\tau$. The fraction is $fT > \\text{MIC} = \\tau/\\tau = 1$.\nIf $f_u C_{max}^{ss} \\le \\text{MIC}$, the free concentration is never above the MIC, so the fraction is $0$.\nOtherwise, if $f_u C_{min}^{ss} \\le \\text{MIC}  f_u C_{max}^{ss}$, the free concentration crosses the MIC at some time $t'_{MIC}$ within the interval. We find this time by setting $f_u C(t'_{MIC}) = \\text{MIC}$:\n$$\nf_u C_{max}^{ss} \\exp(-k_e t'_{MIC}) = \\text{MIC}\n$$\n$$\n\\exp(-k_e t'_{MIC}) = \\frac{\\text{MIC}}{f_u C_{max}^{ss}}\n$$\n$$\n-k_e t'_{MIC} = \\ln \\left( \\frac{\\text{MIC}}{f_u C_{max}^{ss}} \\right)\n$$\n$$\nt'_{MIC} = \\frac{1}{k_e} \\ln \\left( \\frac{f_u C_{max}^{ss}}{\\text{MIC}} \\right)\n$$\nThe fraction of the dosing interval is $fT > \\text{MIC} = \\frac{t'_{MIC}}{\\tau}$.\n\n**4. Numerical Computation**\nFirst, calculate the patient-specific pharmacokinetic parameters from the given per-kilogram values and body weight, $W = 70\\,\\mathrm{kg}$.\n-   Total volume of distribution: $V = V_d \\times W = 0.3\\,\\mathrm{L/kg} \\times 70\\,\\mathrm{kg} = 21\\,\\mathrm{L}$.\n-   Total clearance: $Cl_{total} = Cl \\times W = 0.06\\,\\mathrm{L/kg/h} \\times 70\\,\\mathrm{kg} = 4.2\\,\\mathrm{L/h}$.\n\nNext, calculate the elimination rate constant, $k_e$:\n$$\nk_e = \\frac{Cl_{total}}{V} = \\frac{4.2\\,\\mathrm{L/h}}{21\\,\\mathrm{L}} = 0.2\\,\\mathrm{h^{-1}}\n$$\nThe other parameters are:\n-   Dose: $D = 2\\,\\mathrm{g} = 2000\\,\\mathrm{mg}$.\n-   Dosing interval: $\\tau = 6\\,\\mathrm{h}$.\n-   Unbound fraction: $f_u = 0.7$.\n-   MIC: $\\text{MIC} = 4\\,\\mathrm{mg/L}$.\n\nNow, we evaluate the minimum free concentration at steady state. We first calculate $C_{min}^{ss}$:\n$$\nk_e \\tau = (0.2\\,\\mathrm{h^{-1}}) \\times (6\\,\\mathrm{h}) = 1.2\n$$\n$$\nC_{min}^{ss} = \\frac{(D/V) \\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)} = \\frac{(2000\\,\\mathrm{mg} / 21\\,\\mathrm{L}) \\exp(-1.2)}{1 - \\exp(-1.2)}\n$$\n$$\nC_{min}^{ss} \\approx \\frac{(95.238\\,\\mathrm{mg/L}) \\times 0.30119}{1 - 0.30119} = \\frac{28.696\\,\\mathrm{mg/L}}{0.69881} \\approx 41.064\\,\\mathrm{mg/L}\n$$\nNow, we find the minimum free concentration:\n$$\nC_{u,min}^{ss} = f_u \\times C_{min}^{ss} = 0.7 \\times 41.064\\,\\mathrm{mg/L} \\approx 28.745\\,\\mathrm{mg/L}\n$$\nFinally, we compare this value to the MIC:\n$$\n28.745\\,\\mathrm{mg/L} > 4\\,\\mathrm{mg/L}\n$$\nSince the minimum free drug concentration in the dosing interval is strictly greater than the MIC, the free drug concentration remains above the MIC for the entire duration of the interval.\nTherefore, the time above MIC is equal to the dosing interval, $\\tau$.\nThe fraction of time above MIC is:\n$$\nfT > \\text{MIC} = \\frac{\\tau}{\\tau} = 1\n$$\nThe result is a unitless fraction, as requested.",
            "answer": "$$\n\\boxed{1}\n$$"
        },
        {
            "introduction": "Patient-specific factors, particularly renal function, significantly alter how drugs like penicillins are eliminated from the body. This practice challenges you to perform a clinically vital task: adjusting a dosing regimen for a patient with renal impairment. You will learn to modify the dose and interval to preserve the drug's efficacy, ensuring the therapeutic targets are still met despite physiological changes. ",
            "id": "4970562",
            "problem": "A $70$ kilogram adult is treated for a susceptible bacterial infection with oral amoxicillin. Assume a one-compartment, linear pharmacokinetic model with first-order elimination, negligible absorption lag relative to the dosing interval, oral bioavailability $F = 0.90$, plasma protein binding of $20\\%$ so that the unbound fraction $f_{u} = 0.80$, and volume of distribution $V_{d} = 0.30$ liters per kilogram. At a baseline creatinine clearance of $\\mathrm{CrCl}_{0} = 100$ milliliters per minute, the total body clearance of amoxicillin is $\\mathrm{CL}_{0} = 15.0$ liters per hour, of which the renal component accounts for $70\\%$ and the nonrenal component accounts for $30\\%$. Assume the renal clearance component is directly proportional to creatinine clearance over the range considered, while the nonrenal clearance remains constant.\n\nThe initial regimen is amoxicillin $500$ milligrams orally every $8$ hours targeting pathogens with a minimum inhibitory concentration (MIC) of $1.0$ milligrams per liter. The pharmacodynamic goal is to maintain the same area under the concentration–time curve (AUC) over each dosing interval and the same fraction of time above the minimum inhibitory concentration ($fT > \\text{MIC}$) within each dosing interval when the patient’s renal function declines to $\\mathrm{CrCl}_{1} = 20$ milliliters per minute.\n\nUnder the assumptions above, determine the single new dosing interval $\\tau_{1}$ (in hours) that achieves the pharmacodynamic goal when the per-dose amount is adjusted to keep the AUC over each dosing interval equal to the baseline regimen. Round your final answer to four significant figures and express it in hours. Define and use the following terms at first mention: area under the curve (AUC), minimum inhibitory concentration (MIC), and fraction of time above MIC ($fT > \\text{MIC}$).",
            "solution": "The problem requires the determination of a new dosing interval, $\\tau_1$, for amoxicillin in a patient with decreased renal function. The new regimen must satisfy two pharmacodynamic goals: first, the area under the concentration-time curve per dosing interval must be the same as the baseline regimen, and second, the fraction of the dosing interval where the drug concentration remains above a specific threshold must also be maintained.\n\nFirst, we define the key pharmacodynamic and pharmacokinetic terms.\nThe area under the concentration-time curve (AUC) is a measure of total drug exposure over a defined period. At steady state, the AUC over one dosing interval, $\\mathrm{AUC}_{\\tau}$, is the integral of the drug concentration versus time curve from time $0$ to $\\tau$. For a drug with oral bioavailability $F$, dose $D$, and total body clearance $\\mathrm{CL}$, it is given by $\\mathrm{AUC}_{\\tau} = \\frac{F \\cdot D}{\\mathrm{CL}}$.\nThe minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial drug that will inhibit the visible growth of a microorganism after overnight incubation.\nThe fraction of time above MIC ($fT > \\text{MIC}$) is the percentage of a dosing interval during which the plasma concentration of a drug remains above the MIC. It is a critical pharmacodynamic index for time-dependent antibiotics like amoxicillin. Importantly, only the unbound (free) fraction of the drug is microbiologically active. Therefore, the relevant comparison is between the unbound drug concentration, $C_u(t)$, and the MIC.\n\nThe problem is based on a one-compartment linear pharmacokinetic model with first-order elimination. The statement \"negligible absorption lag\" allows us to model the concentration-time profile after an oral dose as an intravenous bolus administration, where the effective dose is $F \\cdot D$. The concentration $C(t)$ at time $t$ after the dose is given by $C(t) = C_{peak} \\exp(-k_e t)$, where $k_e$ is the first-order elimination rate constant.\n\nThe patient's initial state (subscript $0$) and new state with impaired renal function (subscript $1$) are compared.\n\nStep 1: Calculate the total body clearance in the new state, $\\mathrm{CL}_1$.\nThe baseline total body clearance is $\\mathrm{CL}_{0} = 15.0 \\text{ L/h}$. It consists of renal and nonrenal components.\nBaseline renal clearance: $\\mathrm{CL}_{R,0} = 0.70 \\times \\mathrm{CL}_{0} = 0.70 \\times 15.0 \\text{ L/h} = 10.5 \\text{ L/h}$.\nBaseline nonrenal clearance: $\\mathrm{CL}_{NR,0} = 0.30 \\times \\mathrm{CL}_{0} = 0.30 \\times 15.0 \\text{ L/h} = 4.5 \\text{ L/h}$.\n\nThe nonrenal clearance is assumed to be constant, so $\\mathrm{CL}_{NR,1} = \\mathrm{CL}_{NR,0} = 4.5 \\text{ L/h}$.\nThe renal clearance is proportional to the creatinine clearance ($\\mathrm{CrCl}$).\nThe baseline $\\mathrm{CrCl}_{0} = 100 \\text{ mL/min}$, and the new value is $\\mathrm{CrCl}_{1} = 20 \\text{ mL/min}$.\nThe new renal clearance is:\n$$ \\mathrm{CL}_{R,1} = \\mathrm{CL}_{R,0} \\times \\frac{\\mathrm{CrCl}_{1}}{\\mathrm{CrCl}_{0}} = 10.5 \\text{ L/h} \\times \\frac{20}{100} = 2.1 \\text{ L/h} $$\nThe new total body clearance is the sum of the components:\n$$ \\mathrm{CL}_1 = \\mathrm{CL}_{R,1} + \\mathrm{CL}_{NR,1} = 2.1 \\text{ L/h} + 4.5 \\text{ L/h} = 6.6 \\text{ L/h} $$\n\nStep 2: Establish the dose adjustment rule.\nThe first condition is that the AUC per dosing interval is maintained: $\\mathrm{AUC}_{\\tau,1} = \\mathrm{AUC}_{\\tau,0}$.\n$$ \\frac{F \\cdot D_1}{\\mathrm{CL}_1} = \\frac{F \\cdot D_0}{\\mathrm{CL}_0} $$\nThis gives the rule for adjusting the dose $D_1$ for the new regimen:\n$$ D_1 = D_0 \\frac{\\mathrm{CL}_1}{\\mathrm{CL}_0} $$\n\nStep 3: Formulate the equation for the fraction of time above MIC.\nThe target is to maintain the same $fT > \\text{MIC}$. This means the time the unbound concentration $C_u(t) = f_u C(t)$ is above the MIC must be the same fractional duration of the respective dosing intervals.\n$$ C_u(t) > \\text{MIC} \\implies f_u C(t) > \\text{MIC} \\implies C(t) > \\frac{\\text{MIC}}{f_u} $$\nWe define an effective MIC for total drug concentration, $\\text{MIC}_{eff} = \\frac{\\text{MIC}}{f_u}$.\nGiven $\\text{MIC} = 1.0 \\text{ mg/L}$ and $f_u = 0.80$:\n$$ \\text{MIC}_{eff} = \\frac{1.0 \\text{ mg/L}}{0.80} = 1.25 \\text{ mg/L} $$\n\nThe total volume of distribution is $V_d = 0.30 \\text{ L/kg} \\times 70 \\text{ kg} = 21 \\text{ L}$.\nThe elimination rate constants are $k_e = \\mathrm{CL}/V_d$.\n$k_{e,0} = \\frac{\\mathrm{CL}_0}{V_d} = \\frac{15.0 \\text{ L/h}}{21 \\text{ L}} = \\frac{5}{7} \\text{ h}^{-1}$.\n$k_{e,1} = \\frac{\\mathrm{CL}_1}{V_d} = \\frac{6.6 \\text{ L/h}}{21 \\text{ L}} = \\frac{2.2}{7} \\text{ h}^{-1}$.\n\nThe product $k_{e,0} \\tau_0 = (\\frac{5}{7} \\text{ h}^{-1}) \\times 8 \\text{ h} = \\frac{40}{7} \\approx 5.7 \\gg 1$. This indicates that drug accumulation at steady state is negligible. We can therefore approximate the peak concentration at steady-state, $C_{ss,max}$, with the peak concentration after a single dose, $C_{peak} = \\frac{F D}{V_d}$.\nThe time duration $T_{>\\text{MIC}}$ within an interval where $C(t) > \\text{MIC}_{eff}$ is found by solving:\n$$ C_{peak} \\exp(-k_e T_{>\\text{MIC}}) = \\text{MIC}_{eff} \\implies \\frac{F D}{V_d} \\exp(-k_e T_{>\\text{MIC}}) = \\text{MIC}_{eff} $$\n$$ T_{>\\text{MIC}} = \\frac{1}{k_e} \\ln\\left(\\frac{F D}{V_d \\cdot \\text{MIC}_{eff}}\\right) $$\nThe fraction of time is $fT_{>\\text{MIC}} = \\frac{T_{>\\text{MIC}}}{\\tau} = \\frac{1}{k_e \\tau} \\ln\\left(\\frac{F D}{V_d \\cdot \\text{MIC}_{eff}}\\right)$.\n\nStep 4: Solve for the new dosing interval $\\tau_1$.\nThe second condition is $(fT_{>\\text{MIC}})_1 = (fT_{>\\text{MIC}})_0$.\n$$ \\frac{1}{k_{e,1} \\tau_1} \\ln\\left(\\frac{F D_1}{V_d \\cdot \\text{MIC}_{eff}}\\right) = \\frac{1}{k_{e,0} \\tau_0} \\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right) $$\nSubstitute $D_1 = D_0 \\frac{\\mathrm{CL}_1}{\\mathrm{CL}_0}$:\n$$ \\frac{1}{k_{e,1} \\tau_1} \\ln\\left(\\frac{F D_0 (\\mathrm{CL}_1/\\mathrm{CL}_0)}{V_d \\cdot \\text{MIC}_{eff}}\\right) = \\frac{1}{k_{e,0} \\tau_0} \\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right) $$\nUsing the property of logarithms $\\ln(ab) = \\ln(a) + \\ln(b)$:\n$$ \\frac{1}{k_{e,1} \\tau_1} \\left[ \\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right) + \\ln\\left(\\frac{\\mathrm{CL}_1}{\\mathrm{CL}_0}\\right) \\right] = \\frac{1}{k_{e,0} \\tau_0} \\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right) $$\nSolving for $\\tau_1$:\n$$ \\tau_1 = \\tau_0 \\frac{k_{e,0}}{k_{e,1}} \\frac{\\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right) + \\ln\\left(\\frac{\\mathrm{CL}_1}{\\mathrm{CL}_0}\\right)}{\\ln\\left(\\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}}\\right)} = \\tau_0 \\frac{\\mathrm{CL}_0}{\\mathrm{CL}_1} \\left( 1 + \\frac{\\ln(\\mathrm{CL}_1/\\mathrm{CL}_0)}{\\ln(F D_0 / (V_d \\cdot \\text{MIC}_{eff}))} \\right) $$\nNow, we substitute the numerical values:\n$\\tau_0 = 8 \\text{ h}$\n$\\mathrm{CL}_0/\\mathrm{CL}_1 = 15.0 / 6.6 = 25/11$\n$\\mathrm{CL}_1/\\mathrm{CL}_0 = 6.6 / 15.0 = 0.44$\nThe argument of the main logarithm is:\n$$ \\frac{F D_0}{V_d \\cdot \\text{MIC}_{eff}} = \\frac{0.90 \\times 500 \\text{ mg}}{21 \\text{ L} \\times 1.25 \\text{ mg/L}} = \\frac{450}{26.25} = \\frac{120}{7} $$\n$$ \\ln\\left(\\frac{120}{7}\\right) \\approx 2.84156 $$\n$$ \\ln\\left(\\frac{\\mathrm{CL}_1}{\\mathrm{CL}_0}\\right) = \\ln(0.44) \\approx -0.82098 $$\nSubstituting these into the equation for $\\tau_1$:\n$$ \\tau_1 = 8 \\cdot \\frac{25}{11} \\left( 1 + \\frac{-0.82098}{2.84156} \\right) = \\frac{200}{11} \\left( 1 - 0.28890 \\right) $$\n$$ \\tau_1 = \\frac{200}{11} \\times 0.71110 = 18.1818... \\times 0.71110 \\approx 12.92909 \\text{ hours} $$\nRounding to four significant figures, the new dosing interval is $12.93$ hours.",
            "answer": "$$ \\boxed{12.93} $$"
        },
        {
            "introduction": "Real-world antibiotic therapy involves a dynamic battle between drug, pathogen, and patient. This advanced practice moves beyond simple calculations to predictive analysis, asking you to evaluate how factors like high bacterial load, resistance mechanisms, and infusion strategies can lead to treatment failure. By analyzing these scenarios, you will develop the critical thinking skills needed to anticipate and overcome challenges in clinical practice. ",
            "id": "4970471",
            "problem": "A clinician treats a bloodstream infection with piperacillin/tazobactam in a $70$ $\\mathrm{kg}$ adult. You are asked to predict conditions that will most likely lead to treatment failure based on first principles of pharmacokinetics and pharmacodynamics for time-dependent $\\beta$-lactams. Use the following foundational facts and parameters:\n\n- For penicillins, bactericidal activity correlates with maintaining free (unbound) drug concentrations above the minimum inhibitory concentration (MIC) for a sufficient fraction of the dosing interval. Mechanistically, target engagement of penicillin-binding proteins (PBPs) follows a ligand-occupancy relation $\\theta = \\dfrac{C_{\\mathrm{free}}}{C_{\\mathrm{free}} + K_D}$. Assume that a bactericidal effect requires $\\theta \\ge 0.6$ for at least $50\\%$ of each dosing interval. If $K_D \\approx \\mathrm{MIC}$, this is equivalent to requiring $C_{\\mathrm{free}} \\ge 1.5 \\times \\mathrm{MIC}$ for at least $50\\%$ of the interval.\n- Piperacillin exhibits first-order elimination with half-life $t_{1/2} = 1.2$ $\\mathrm{h}$, so $k = (\\ln 2)/t_{1/2}$, and has volume of distribution $V_d = 0.25$ $\\mathrm{L/kg}$ (use $V_d = 17.5$ $\\mathrm{L}$ for $70$ $\\mathrm{kg}$). Protein binding is $30\\%$, so the free fraction is $f_u = 0.7$.\n- Unless otherwise stated, the regimen is piperacillin/tazobactam $4.5$ $\\mathrm{g}$ ($4.0$ $\\mathrm{g}$ piperacillin $+$ $0.5$ $\\mathrm{g}$ tazobactam) every $6$ $\\mathrm{h}$ ($q6h$), infused over $0.5$ $\\mathrm{h}$. You may assume negligible accumulation across intervals given the parameter values.\n- Inoculum effect: increasing bacterial burden increases $\\beta$-lactamase mass, which can consume tazobactam and raise the apparent piperacillin/tazobactam MIC at high inoculum.\n- MIC scenarios (piperacillin/tazobactam): at standard inoculum $10^5$ colony-forming units per milliliter (CFU/mL) with low $\\beta$-lactamase expression, $\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$. At high inoculum $10^7$ $\\mathrm{CFU/mL}$ with strong $\\beta$-lactamase induction and partial inhibitor saturation, the effective $\\mathrm{MIC}$ rises to $64$ $\\mathrm{mg/L}$. For hyperproduced Ambler class C cephalosporinase (AmpC) that is poorly inhibited by tazobactam, the effective $\\mathrm{MIC}$ is $128$ $\\mathrm{mg/L}$.\n\nWhich of the following scenarios are most likely to result in piperacillin/tazobactam treatment failure because the occupancy threshold is not sustained (i.e., free piperacillin concentration fails to remain at or above $1.5 \\times \\mathrm{MIC}$ for at least $50\\%$ of the dosing interval)? Select all that apply.\n\nA. Standard inoculum $10^5$ $\\mathrm{CFU/mL}$ with low $\\beta$-lactamase expression ($\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$); regimen $4.5$ $\\mathrm{g}$ $q6h$ infused over $0.5$ $\\mathrm{h}$.\n\nB. High inoculum $10^7$ $\\mathrm{CFU/mL}$ with inducible TEM-type $\\beta$-lactamase leading to inhibitor saturation (effective $\\mathrm{MIC} = 64$ $\\mathrm{mg/L}$); regimen $4.5$ $\\mathrm{g}$ $q6h$ infused over $0.5$ $\\mathrm{h}$.\n\nC. High inoculum $10^7$ $\\mathrm{CFU/mL}$ with strong $\\beta$-lactamase induction (effective $\\mathrm{MIC} = 64$ $\\mathrm{mg/L}$) and switch to prolonged piperacillin infusion of $3$ $\\mathrm{h}$ at the same $q6h$ frequency and total dose.\n\nD. Standard inoculum $10^5$ $\\mathrm{CFU/mL}$, but the organism hyperproduces chromosomal AmpC (poorly inhibited by tazobactam), yielding effective $\\mathrm{MIC} = 128$ $\\mathrm{mg/L}$; regimen $4.5$ $\\mathrm{g}$ $q6h$ infused over $0.5$ $\\mathrm{h}$.\n\nE. Standard inoculum $10^5$ $\\mathrm{CFU/mL}$ with low $\\beta$-lactamase expression ($\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$); interval extended to every $8$ $\\mathrm{h}$ ($q8h$), infusion over $0.5$ $\\mathrm{h}$ at the same dose.",
            "solution": "The user has provided a problem in clinical pharmacology that requires a quantitative analysis of pharmacokinetic/pharmacodynamic (PK/PD) principles for a $\\beta$-lactam antibiotic, piperacillin. The task is to identify clinical scenarios that are likely to lead to treatment failure based on a defined PD target.\n\n### Step 1: Extract Givens\n- **Patient**: $70$ $\\mathrm{kg}$ adult.\n- **Drug**: Piperacillin/tazobactam.\n- **Pharmacodynamic Target for Failure**: The fraction of the dosing interval ($\\tau$) during which the free drug concentration ($C_{\\mathrm{free}}$) is at or above $1.5 \\times \\mathrm{MIC}$ is less than $50\\%$. This is denoted as $\\%fT > 1.5 \\times \\mathrm{MIC}  50\\%$.\n- **Piperacillin Pharmacokinetic Parameters**:\n    - Model: First-order elimination.\n    - Half-life ($t_{1/2}$): $1.2$ $\\mathrm{h}$.\n    - Volume of distribution ($V_d$): $17.5$ $\\mathrm{L}$ (for the $70$ $\\mathrm{kg}$ patient).\n    - Free fraction ($f_u$): $0.7$ (since protein binding is $30\\%$).\n- **Standard Dosing Regimen**:\n    - Piperacillin dose ($D$): $4.0$ $\\mathrm{g}$ ($4000$ $\\mathrm{mg}$).\n    - Dosing interval ($\\tau$): $6$ $\\mathrm{h}$.\n    - Infusion time ($T_{inf}$): $0.5$ $\\mathrm{h}$.\n- **Assumption**: Negligible drug accumulation between doses.\n- **Minimum Inhibitory Concentration (MIC) scenarios**:\n    - Standard inoculum: $\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$.\n    - High inoculum (inducible $\\beta$-lactamase): effective $\\mathrm{MIC} = 64$ $\\mathrm{mg/L}$.\n    - Hyperproduced AmpC cephalosporinase: effective $\\mathrm{MIC} = 128$ $\\mathrm{mg/L}$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is scientifically grounded in established principles of pharmacokinetics and pharmacodynamics. The use of a one-compartment model with IV infusion is standard. The provided PK parameters for piperacillin are clinically accepted values. The PD target of time over MIC is the standard index for $\\beta$-lactams. The MIC scenarios reflect known mechanisms of bacterial resistance and the inoculum effect. The problem is well-posed, providing all necessary data for calculation ($D$, $V_d$, $t_{1/2}$, $f_u$, $T_{inf}$, $\\tau$, and various MICs). The language is objective and precise. The assumption of negligible accumulation is justified, as the dosing interval of $6$ hours is $5$ times the half-life of $1.2$ hours, meaning over $96\\%$ of the drug is eliminated before the next dose. The problem is valid.\n\n### Step 3: Derivation of Solution\nThe solution requires calculating the percentage of the dosing interval that $C_{\\mathrm{free}} \\ge 1.5 \\times \\mathrm{MIC}$. This involves modeling the concentration-time profile of piperacillin.\n\n**Pharmacokinetic Model Equations**\nThe elimination rate constant, $k$, is calculated from the half-life:\n$$k = \\frac{\\ln(2)}{t_{1/2}} = \\frac{0.693}{1.2 \\mathrm{h}} \\approx 0.5776 \\mathrm{h}^{-1}$$\nWe model the drug concentration using a one-compartment model with a short infusion.\n\n1.  **During infusion ($0 \\le t \\le T_{inf}$)**: The rate of infusion is $R_0 = D/T_{inf}$. The total concentration $C(t)$ is:\n    $$C(t) = \\frac{R_0}{V_d k} (1 - e^{-kt})$$\n2.  **After infusion ($t  T_{inf}$)**: The concentration decays exponentially from the peak concentration, $C_{peak}$, which occurs at $t = T_{inf}$.\n    $$C_{peak} = C(T_{inf}) = \\frac{R_0}{V_d k} (1 - e^{-kT_{inf}})$$\n    $$C(t) = C_{peak} e^{-k(t - T_{inf})}$$\n\nThe target for the free concentration is $C_{\\mathrm{free}} \\ge 1.5 \\times \\mathrm{MIC}$. Since $C_{\\mathrm{free}} = f_u C$, this is equivalent to a target for the total concentration:\n$$C(t) \\ge \\frac{1.5 \\times \\mathrm{MIC}}{f_u}$$\nLet's define $C_{target\\_total} = \\frac{1.5 \\times \\mathrm{MIC}}{f_u}$.\n\nWe need to find the total time $t'$ in the interval $[0, \\tau]$ where $C(t) \\ge C_{target\\_total}$. Treatment failure occurs if $t'/\\tau  0.5$.\n\nIf $C_{peak}  C_{target\\_total}$, the target is never met, so $t' = 0$.\nIf $C_{peak} \\ge C_{target\\_total}$, we can calculate the time $t_{cross}$ when the concentration drops to the target:\n$$C(t_{cross}) = C_{target\\_total}$$\n$$C_{peak} e^{-k(t_{cross} - T_{inf})} = C_{target\\_total}$$\n$$t_{cross} - T_{inf} = \\frac{1}{k} \\ln\\left(\\frac{C_{peak}}{C_{target\\_total}}\\right)$$\n$$t_{cross} = T_{inf} + \\frac{1}{k} \\ln\\left(\\frac{C_{peak}}{C_{target\\_total}}\\right)$$\nThe time above target is $t' = t_{cross}$ (assuming the target is first crossed during the elimination phase, which is true for all scenarios where $C_{peak}$ is not dramatically higher than $C_{target\\_total}$).\n\n**Calculation of Constants for the Standard Regimen**\n- Dose $D = 4000$ $\\mathrm{mg}$.\n- Infusion time $T_{inf} = 0.5$ $\\mathrm{h}$.\n- Infusion rate $R_0 = 4000 \\mathrm{mg} / 0.5 \\mathrm{h} = 8000$ $\\mathrm{mg/h}$.\n- $V_d k = 17.5 \\mathrm{L} \\times 0.5776 \\mathrm{h}^{-1} \\approx 10.108$ $\\mathrm{L/h}$.\n- $C_{peak}$ for standard infusion ($T_{inf} = 0.5$ h):\n  $$C_{peak} = \\frac{8000}{10.108} (1 - e^{-0.5776 \\times 0.5}) = 791.45 (1 - e^{-0.2888}) = 791.45 (1 - 0.7492) \\approx 198.5 \\mathrm{mg/L}$$\n\n### Option-by-Option Analysis\n\n**A. Standard inoculum, $\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$, standard regimen ($q6h$, $T_{inf}=0.5$ $\\mathrm{h}$)**\n- $\\tau = 6$ $\\mathrm{h}$.\n- $C_{target\\_total} = \\frac{1.5 \\times 8 \\mathrm{mg/L}}{0.7} = \\frac{12}{0.7} \\approx 17.14$ $\\mathrm{mg/L}$.\n- $C_{peak} \\approx 198.5$ $\\mathrm{mg/L}$, which is greater than $C_{target\\_total}$.\n- Time above target:\n  $$t' = 0.5 \\mathrm{h} + \\frac{1}{0.5776 \\mathrm{h}^{-1}} \\ln\\left(\\frac{198.5}{17.14}\\right) = 0.5 + 1.731 \\ln(11.58) = 0.5 + 1.731(2.45) = 0.5 + 4.24 \\approx 4.74 \\mathrm{h}$$\n- Fraction of interval: $\\frac{t'}{\\tau} = \\frac{4.74 \\mathrm{h}}{6 \\mathrm{h}} \\approx 0.79 = 79\\%$.\n- Since $79\\% > 50\\%$, treatment success is predicted.\n- **Verdict: Incorrect.**\n\n**B. High inoculum, $\\mathrm{MIC} = 64$ $\\mathrm{mg/L}$, standard regimen ($q6h$, $T_{inf}=0.5$ $\\mathrm{h}$)**\n- $\\tau = 6$ $\\mathrm{h}$.\n- $C_{target\\_total} = \\frac{1.5 \\times 64 \\mathrm{mg/L}}{0.7} = \\frac{96}{0.7} \\approx 137.14$ $\\mathrm{mg/L}$.\n- $C_{peak} \\approx 198.5$ $\\mathrm{mg/L}$, which is greater than $C_{target\\_total}$.\n- Time above target:\n  $$t' = 0.5 \\mathrm{h} + \\frac{1}{0.5776 \\mathrm{h}^{-1}} \\ln\\left(\\frac{198.5}{137.14}\\right) = 0.5 + 1.731 \\ln(1.447) = 0.5 + 1.731(0.370) = 0.5 + 0.64 \\approx 1.14 \\mathrm{h}$$\n- Fraction of interval: $\\frac{t'}{\\tau} = \\frac{1.14 \\mathrm{h}}{6 \\mathrm{h}} = 0.19 = 19\\%$.\n- Since $19\\%  50\\%$, treatment failure is predicted.\n- **Verdict: Correct.**\n\n**C. High inoculum, $\\mathrm{MIC} = 64$ $\\mathrm{mg/L}$, prolonged infusion ($q6h$, $T_{inf}=3$ $\\mathrm{h}$)**\n- $\\tau = 6$ $\\mathrm{h}$.\n- Regimen: $D = 4000$ $\\mathrm{mg}$, $T_{inf} = 3$ $\\mathrm{h}$.\n- $R_0 = 4000 \\mathrm{mg} / 3 \\mathrm{h} \\approx 1333.3$ $\\mathrm{mg/h}$.\n- $C_{peak}$ for prolonged infusion:\n  $$C_{peak} = \\frac{1333.3}{10.108} (1 - e^{-0.5776 \\times 3}) = 131.9 (1 - e^{-1.7328}) = 131.9 (1 - 0.1768) \\approx 108.6 \\mathrm{mg/L}$$\n- $C_{target\\_total} = \\frac{1.5 \\times 64 \\mathrm{mg/L}}{0.7} \\approx 137.14$ $\\mathrm{mg/L}$.\n- Here, $C_{peak} \\approx 108.6 \\mathrm{mg/L}$ is less than $C_{target\\_total} \\approx 137.14 \\mathrm{mg/L}$. The total drug concentration never reaches the required threshold.\n- Therefore, the time above target is $t' = 0$.\n- Fraction of interval: $\\frac{t'}{\\tau} = \\frac{0 \\mathrm{h}}{6 \\mathrm{h}} = 0 = 0\\%$.\n- Since $0\\%  50\\%$, treatment failure is predicted.\n- **Verdict: Correct.**\n\n**D. Hyperproduced AmpC, $\\mathrm{MIC} = 128$ $\\mathrm{mg/L}$, standard regimen ($q6h$, $T_{inf}=0.5$ $\\mathrm{h}$)**\n- $\\tau = 6$ $\\mathrm{h}$.\n- $C_{peak} \\approx 198.5$ $\\mathrm{mg/L}$ (from standard regimen calculation).\n- $C_{target\\_total} = \\frac{1.5 \\times 128 \\mathrm{mg/L}}{0.7} = \\frac{192}{0.7} \\approx 274.3$ $\\mathrm{mg/L}$.\n- Here, $C_{peak} \\approx 198.5 \\mathrm{mg/L}$ is less than $C_{target\\_total} \\approx 274.3 \\mathrm{mg/L}$.\n- The concentration never reaches the required threshold. The time above target is $t' = 0$.\n- Fraction of interval: $\\frac{t'}{\\tau} = \\frac{0 \\mathrm{h}}{6 \\mathrm{h}} = 0 = 0\\%$.\n- Since $0\\%  50\\%$, treatment failure is predicted.\n- **Verdict: Correct.**\n\n**E. Standard inoculum, $\\mathrm{MIC} = 8$ $\\mathrm{mg/L}$, extended interval ($q8h$, $T_{inf}=0.5$ $\\mathrm{h}$)**\n- $\\tau = 8$ $\\mathrm{h}$.\n- This scenario uses the same MIC and single-dose PK profile as option A.\n- Time above target $t'$ is the same as calculated for option A: $t' \\approx 4.74 \\mathrm{h}$.\n- The dosing interval is now $\\tau = 8$ $\\mathrm{h}$.\n- Fraction of interval: $\\frac{t'}{\\tau} = \\frac{4.74 \\mathrm{h}}{8 \\mathrm{h}} \\approx 0.59 = 59\\%$.\n- Since $59\\% > 50\\%$, treatment success is predicted.\n- **Verdict: Incorrect.**\n\nIn summary, the scenarios likely to result in treatment failure, because the pharmacodynamic target is not met, are B, C, and D.",
            "answer": "$$\\boxed{BCD}$$"
        }
    ]
}